Menu

Experience

Matthew Pavao

    • Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche 


    • Reata Pharmaceuticals – $505 Million Follow-On Offering 


    • ERYTECH – $144 Million IPO 


    • Selecta Biosciences – $74 Million IPO 


    • Inotek Pharmaceuticals – $50 Million Follow-On 


    • Voyager Therapeutics - $80.5 Million IPO